Gabapentin
- Product NDC
- 51407-047
- 11-digit product format
- 514070047
- Labeler code
- 51407
- Product ID
- 51407-047_e808aa6f-9f78-285b-e053-2a95a90a2b21
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA204989
- Marketing category
- ANDA
- Marketing start
- 2016-02-18
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 51407-047 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 51407-047 | 51407-047-10 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 51407-047 | 51407-047-18 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 51407-047 | 51407-047-27 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 51407-047 | 51407-047-90 | D | Discontinued by firm | 2026-10-05 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204989-001 | RELGAABI | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | |
| A204989-002 | RELGAABI | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | |
| A204989-003 | RELGAABI | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | |
| A204989-004 | RELGAABI | GABAPENTIN | 200MG | CAPSULE / ORAL | AB | 2026-03-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204989-001 | AB |
| A204989-002 | AB |
| A204989-003 | AB |
| A204989-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204989-001 | RELGAABI | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204989-002 | RELGAABI | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204989-003 | RELGAABI | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204989-004 | RELGAABI | 200MG | CAPSULE / ORAL | AB | 2026-03-06 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A204989-001 | RELGAABI | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204989-002 | RELGAABI | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204989-003 | RELGAABI | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204989-004 | RELGAABI | 200MG | CAPSULE / ORAL | AB | 2026-03-06 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204989-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2016-02-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204989-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2016-02-18 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204989-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2016-02-18 | 79d66fd596c7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204989-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204989-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204989-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204989-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A204989-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204989-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204989-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204989-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A204989-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204989-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204989-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204989-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204989-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204989-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A204989-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204989-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204989-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204989-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204989-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204989-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204989-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204989-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204989-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204989-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204989-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204989-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204989-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204989-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204989-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204989-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204989-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204989-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204989-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204989-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204989-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A204989-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204989-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204989-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204989-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204989-002 | AB | 1 | 79d66fd596c7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51407-047-10 | Gabapentin | 1000 in 1 BOTTLE, PLASTIC | CAPSULE | 1000 | 11 | |
| 51407-047-18 | Gabapentin | 180 in 1 BOTTLE, PLASTIC | CAPSULE | 180 | 11 | |
| 51407-047-27 | Gabapentin | 270 in 1 BOTTLE, PLASTIC | CAPSULE | 270 | 11 | |
| 51407-047-90 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | CAPSULE | 90 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51407-047-10 | EA - Each | 51407-047 | 72dc3699-123f-4233-990d-9c0206bcb3a3 | 1 | 2018-11-06 |
| 51407-047-18 | EA - Each | 51407-047 | 5f6c93be-0145-4cd7-ae44-7090db73a71c | 1 | 2018-11-06 |
| 51407-047-27 | EA - Each | 51407-047 | 814dc6a6-c6fb-4de4-b604-1890938482ca | 1 | 2018-11-06 |
| 51407-047-90 | EA - Each | 51407-047 | 74fa51d1-baa1-42aa-b2d4-46604d496cf0 | 1 | 2018-11-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Quality Care Products, LLC | ed3a0d48-2e98-44ee-8743-880d1221a480 | 2024-12-18 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 481e6b68-50e4-4594-9815-32580a84ab8c | 2024-12-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Westminster Pharmaceuticals, LLC | 2f70c496-b58c-30f5-e054-00144ff8d46c | 2024-10-31 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Creekwood Pharmaceuticals LLC | 26aac429-a5cd-33cc-e063-6394a90aecc0 | 2024-09-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Medsource Pharmaceuticals | 12f0c2ee-9a44-9778-e063-6294a90a3b58 | 2024-03-05 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 1749d731-bc8c-4374-b2a9-7c809c457f56 | 2024-03-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 22f2294f-352a-4515-87c8-a6ae46e61322 | 2023-05-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f7a943ec-9a13-45ba-9bc5-18162b86b921 | 2023-01-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 20e48004-d8b6-40fd-929b-b95087b4d85d | 2022-11-28 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 88ac51c4-5fa9-4c35-9c63-f26bcb101d4b | 2022-10-18 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | ed22b78e-93ff-4cb5-9c9c-2afe9b60dd2e | 2022-05-02 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 223a9216-6e07-49b9-8faf-bb4e529a6ae5 | 2022-04-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 52af51ab-6543-466b-848c-13c588c98789 | 2022-04-01 | Warnings, Adverse reactions | 204989 ANDA204989 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 1b73e9db-eddb-49ba-9778-01d39ece4d16 | 2018-09-21 | Warnings, Adverse reactions | 204989 ANDA204989 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310430 | gabapentin 100 MG Oral Capsule | PSN | 76f5eff8-698f-2753-e053-2991aa0ae7f9 | 12 |
| 310431 | gabapentin 300 MG Oral Capsule | PSN | 76f5eff8-698f-2753-e053-2991aa0ae7f9 | 12 |
| 310432 | gabapentin 400 MG Oral Capsule | PSN | 76f5eff8-698f-2753-e053-2991aa0ae7f9 | 12 |
| 310430 | gabapentin 100 MG Oral Capsule | SCD | 76f5eff8-698f-2753-e053-2991aa0ae7f9 | 12 |
| 310431 | gabapentin 300 MG Oral Capsule | SCD | 76f5eff8-698f-2753-e053-2991aa0ae7f9 | 12 |
| 310432 | gabapentin 400 MG Oral Capsule | SCD | 76f5eff8-698f-2753-e053-2991aa0ae7f9 | 12 |
| 310430 | gabapentin 100 MG Oral Capsule | PSN | 20e48004-d8b6-40fd-929b-b95087b4d85d | 7 |
| 310430 | gabapentin 100 MG Oral Capsule | SCD | 20e48004-d8b6-40fd-929b-b95087b4d85d | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51407-047-10 | 51407004710 | 1000 CAPSULE in 1 BOTTLE, PLASTIC (51407-047-10) | 1000 capsule | 2018-09-12 | 0000-00-00 | No | No | Current |
| 51407-047-18 | 51407004718 | 180 CAPSULE in 1 BOTTLE, PLASTIC (51407-047-18) | 180 capsule | 2018-09-12 | 0000-00-00 | No | No | Current |
| 51407-047-27 | 51407004727 | 270 CAPSULE in 1 BOTTLE, PLASTIC (51407-047-27) | 270 capsule | 2018-09-12 | 0000-00-00 | No | No | Current |
| 51407-047-90 | 51407004790 | 90 CAPSULE in 1 BOTTLE, PLASTIC (51407-047-90) | 90 capsule | 2018-09-12 | 0000-00-00 | No | No | Current |